Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4385_Библиотеки_им_академика_М_И_Перельмана
.pdf
AETIOLOGY OF HEAD AND NECK CANCER
countries. When marijuana is smoked, a wide range of potential carcinogens are released
and absorbed, with an overall risk of 2.6 compared to non-users.
Alcohol
Alcohol is believed to act in a synergistic fashion with tobacco; however, some case control
and cohort studies have shown an increased risk of cancer even in non-smokers. Alcohol
itself is not a carcinogen, so possible carcinogenic mechanisms include alcohol acting as a
solvent, non-alcohol constituents of alcoholic drinks, the alcohol metabolite acetaldehyde,
activation of the cytochrome p450 system, decreased activity of DNA repair enzymes or
T cells or the associated nutritional deciencies associated with heavy alcohol intake.
Dental Factors
Poor oral hygiene is associated with oral cancer. is may be due to chronic inammation
of the gingiva or an alteration in the oral microbiome. ere is some evidence suggesting
mouthwashes containing alcohol may also be important.
Infections
In oral cancer, several viruses have been implicated in carcinogenesis including HPV, human
immunodeciency virus (HIV) and herpes simplex virus (HSV).
Human Papillomavirus
Some authors have dismissed a link between oral cavity cancer and HPV infection due to low
prevalence. In contrast, other authors have reported that the infection of oral cavity cells by
HPV is not rare, and the relationship is not resolved.
Human Immunodeciency Virus
A study from New York showed HIV infection in 5% of head and neck cancer patients. Due
to the depressed immunity in HIV patients, the head and neck cancers observed were more
advanced in the HIV group.
Herpes Simplex Virus
Several studies have shown that patients with oral cancer have higher antibodies to HSV.
However, there is little evidence that HSV gene sequences are present in oral cancer cells or
any evidence of gene integration.
Nutritional Factors
Several studies suggest high fruit and vegetable intake is associated with a decreased risk of
head and neck cancer. is may be due to increased intake of the antioxidants or free radical
scavenging vitamins A, C and E.
Genetic and Immunologic Predisposition
Although smoking is the main risk factor, not all people who smoke develop head and neck
cancer. ere are several genetic conditions that are associated with increased risk of head
and neck cancer including Li-Fraumeni syndrome (p53 gene mutation), Fanconi’s anaemia,
Bloom syndrome and ataxia-telangiectasia.
Patients treated with bone marrow transplants and organ transplants have an increased incidence of skin cancer and oral cavity cancer, possibly due to the long-term use of immunosuppressive drugs.
Cancer of the Oropharynx
Recent studies have shown a dramatic change in the aetiology of oropharyngeal cancer from
a cancer caused by smoking and alcohol to a cancer now predominantly caused by HPV. e
increase in tonsil and base of tongue cancer over the last decade is largely due to HPV infection of the palatine and lingual tonsils, and it has been called an epidemic of HPV-associated
oropharyngeal cancer.
258 Head and Neck

AETIOLOGY OF HEAD AND NECK CANCER
HPV exists in many dierent serotypes and HPV 16, 18, 31, 33, 35 and 39 are associated with
head and neck c ancer and HPV 16 and 18 are the most com mon types as sociated with squ amous
cell carcinoma. e E6 and E7 open reading frames (ORFs) of the high-risk HPVs are important. ey bind to and inactivate tumour suppressor genes p53 and pRb, respectively, allowing
uncontrolled cell proliferation, resulting in genomic instability and cellular transformation.
Patients with HPV-positive tonsil cancer tend to be young, non-smokers and non-drinkers.
e molecular characteristics are completely dierent from HPV-negative tonsil cancers.
HPV-positive tonsil cancers have shown a better prognosis.
Cancer of the Larynx and Hypopharynx
e numbers of new cases of laryngeal cancer are falling by around 2% to 3% a year, mainly
because fewer people are smoking.
Tobacco and Alcohol
ere is a strong association between laryngeal c ancer and cigarette smoking. Environmental
tobacco smoke also increases the risk of laryngeal cancer. e combined use of tobacco and
alcohol increases the risk of laryngeal cancer by 50% over the estimated risk if these factors were considered additive. e risk is greater for hypopharyngeal cancer than laryngeal
cancer.
Other Factors
Laryngeal cancer is also associated with nickel and mustard gas exposure and there may be
association with asbestos exposure. Postcricoid carcinoma is associated with previous radiation and sideropenic dysphagia - between 4% and 6% of patients have a history of PlummerVinson syndrome.
Cancer of the Nasopharynx
Nasopharyngeal cancer (NPC) is endemic in southern China and Hong Kong with an incidence rate of 50 per 100 000.
ere are three subtypes: World Health Organisation (WHO) type 1, keratinising squamous
cell carcinoma; WHO type 2, non-keratinising (dierentiated) carcinoma and WHO type 3,
undierentiated carcinoma. In North America, type 1 accounts for 68% of cases whereas in
the Far East, types 2 and 3 account for 95% of cases. ere is a genetic association, with dierent types of HLA types, and a familial association. e most important environmental factor
is infection by Epstein-Barr virus (EBV).
Dietary factors are also important. People who live in aected areas where NPC is common
typically eat diets very high in salt-cured sh and meat. Studies indicate that foods preserved in
this way that are cooked at high temperatures may produce chemicals that can damage DNA.
Cancer of the Nasal Cavity and Paranasal Sinuses
Cancers of the nasal cavity and paranasal sinuses are rare. As in all head and neck cancer,
smoking tobacco is a risk factor for nasal cavity cancer. Occupational factors are also important including exposure to dust from wood, textiles and leather and possibly our.
Non-Squamous Malignant Tumours
Carcinoma of the Thyroid
Dierentiated thyroid cancer (DTC) accounts for 80% of thyroid cancers, split into papillary and follicular cancer. Other thyroid tumours include poorly dierentiated cancer (10%),
anaplastic (5%) and medullary thyroid cancer (MTC; 5%). e incidence of papillary thyroid
cancer is increasing, which is partly the result of the incidental detection of early thyroid
cancer because of increasing use of imaging.
yroid cancer is more common in areas of the world where diets are low in iodine, but there
is not a strong epidemiological relationship between iodine intake and cancer. A history of
radiation treatment in childhood is a known risk factor. Inherited medical conditions such
Head and Neck 259

AETIOLOGY OF HEAD AND NECK CANCER
as Gardner syndrome, familial polyposis and Cowden disease have an increased incidence of
thyroid cancer. Certain families also have an increased incidence of papillary thyroid cancer.
MTC originates from the parafollicular C cells, secretes calcitonin and occurs in both sporadic and hereditary forms. Seventy-ve percent of MTC occurs as a sporadic form and 25%
as a hereditary form. e hereditary forms can occur in the hereditary syndrome multiple
endocrine neoplasia syndrome type A (MEN-2A), in MEN-2B or as a single component in a
hereditary disease (familial MTC). Both MEN-2 syndromes are autosomal dominant genetic
disorders characterised by mutations in the RET proto-oncogene.
Salivary Gland Carcinomas
Exposure to radiation to the head and neck area increases the risk of salivary gland cancer. Some studies have also suggested that working with certain metals (nickel alloy dust)
and minerals (silica dust) may increase the risk for salivary gland cancer. In men, smoking
and heavy alcohol consumption was also associated with higher risk, but not in women.
Hormonal dependence may also be important; early menarche and nulliparity are associated with increased risk, whereas older age at full-term pregnancy and long duration of oral
contraceptive use are associated with reduced risk.
Sarcomas of the Head and Neck
Sarcomas of t he head and neck constitute less than 1% of head and neck malig nancies. ey are
divided into those arising from so tissue (STS) and those arising from bone (osteosarcoma).
Genetic Predisposition
Studies have shown that some groups of individuals are at an increased risk of developing
STS. Among them are genetically predisposed individuals, such as those suering from neurobromatosis (who are at risk of malignant peripheral neuroectodermal tumour [MPNT]),
Li-Fraumeni syndrome and children with retinoblastoma (who are predisposed to osteosarcoma, rhabdomyosarcoma and brosarcoma). Other heritable syndromes associated with an
increased risk of STS include Gardner syndrome and nevoid basal cell carcinoma syndrome.
Radiation, Viruses and Other Factors
Previous exposure to irradiation is another well-documented risk for both STS and osteogenic sarcoma in other sites, but the head and neck is less commonly aected. Patients with
chronic lymphoedema have an increased incidence of STS formation. Patients with Paget’s
disease of bone, particularly the skull, are predisposed to osteogenic sarcoma. e role of
viruses in the pathogenesis of STS has been investigated, but apart from the association of
HIV with Kaposi’s sarcoma there is no conclusive proof available for a viral aetiology.
KEY POINTS
• Squamous cell cancer is the most common head and neck malignancy, and it is related
mainly to alcohol and tobacco use.
• HPV is now the leading cause of cancer of the oropharynx.
• Other malignancies of the head and neck such as thyroid cancer, salivary gland cancer
and sarcomas are not related to alcohol or tobacco usage. The main causes of these
cancers are less clear. Prior exposure to radiation in the head and neck area is one of
the few identied risk factors.
• Genetic predisposition to head and neck cancer is rare and is present in a few inherited
conditions such as Fanconi’s anaemia and Li-Fraumeni syndrome. MTC is a well-known
example of a hereditary thyroid cancer secondary to a specic mutation in RET oncogene.
There is an important role of head and neck cancer prevention through alcohol and
tobacco cessation, HPV vaccination and close follow-up of risk groups such as genetic
conditions carriers.
260 Head and Neck

MOLECULAR BIOLOGY AND GENE THERAPY
52. MOLECULAR BIOLOGY AND GENE THERAPY
Molecular Genetics: DNA Structure and Function
Hereditary information in eukaryotes is stored in the form of double-stranded deoxyribonucleic acid (DNA) and is referred to as the genome. DNA forms a double helix structure bonding complementary pairs of nucleotides, such as adenine (A) with thymine (T)
and cytosine (C) with guanine (G). Within the coding part of DNA nucleotides on each
strand are grouped in triplets, known as codons. Each codon sequence determines a single specic amino acid. Some codons are ‘stop’ codons, constituting a signal for arrest
of translation. e overwhelming majority of DNA (99.9%) exists in the cell nucleus as
the nuclear genome and the remaining DNA forms the mitochondrial genome, encoding
37 genes.
Each DNA molecule is packaged into a chromosome by complex folding of the DNA around
proteins. Diploid human cells contain 22 pairs and a pair of sex chromosomes (XX or XY)
that determines the sex of the organism. One of each pair of chromosomes is maternally
inherited and the other is paternally inherited. e ends of the chromosomes are capped by
telomeres, which are specialised structures that are involved in cell mortality. During normal cell division, DNA replication is achieved by the separation of the two strands by DNA
helicase. Each separated single strand then acts as a template for forming a new complementary strand.
A gene is a region of the chromosomal DNA that produces a functional ribonucleic acid
molecule (RNA). It comprises regulatory DNA sequences that determine when and in which
cell types that gene is expressed; exons are coding sequences and interspersed introns are
non-coding DNA sequences.
Transcription is the intra-nuclear process driven by the RNA polymerase whereby one DNA
strand acts as a template for the synthesis of an RNA strand (uracil replaces thymine in
RNA). is primary RNA transcript then undergoes post-transcriptional processing, or
splicing. e mature mRNA migrates into the cytoplasm where it acts as a template for
the synthesis of a polypeptide during translation, via ribosomes. Successive amino acids
are added creating a polypeptide chain from to the triplet code on the mRNA, resulting in
protein synthesis.
Other Regulators of Gene Expression
Small interfering RNAs (siRNAs; double stranded) and microRNAs (miRs; single stranded)
are biologically signicant post-transcriptional regulators of gene expression. siRNAs and
miRs are non-coding RNA molecules that base pair with mRNA via the RISC complex, preventing their translation into proteins. In addition, long non-coding RNAs (ncRNAs) have
been identied that are thought to regulate various aspects of gene expression and they have
been implicated in a number of diseases, including aging and cancer.
Molecular Aberrations of Cellular Biology
DNA mutation may occur as a result of base substitutions, as well as nucleotide insertions
and deletions. Insertions and deletions of nucleotides are very rare in coding DNA. Base
substitution is a more common form of mutation in coding DNA, which may have a range of
consequences on the function of the gene: a loss of function; a gain in function, oen due to
stabilisation of the active protein or no net functional eect. An example of a silent substitution yielding no functional eect is seen when an amino acid may be encoded by dierent
codons (e.g. GUA, GAC, GUG and GUU all encode valine), so a substitution of the third
base results in no change to the amino acid. At the other extreme is the nonsense mutation,
whereby a base substitution results in an early stop codon, which leads to truncation of the
polypeptide and a dramatic reduction in function.
Head and Neck 261

MOLECULAR BIOLOGY AND GENE THERAPY
A proto-oncogene may be converted into an oncogene by a point mutation or by a simple
increase in the copy number of the gene (gene amplication) resulting in an overproduction of protein. Loss of function of a tumour suppressor gene is also oncogenic, which
can occur a number of ways, including a missense mutation causing loss of protein function, an early stop codon and transcriptional silencing. e methylation status of CpG
islands surrounding the promoter regions of genes determines whether a particular gene
is expressed within a cell, such that methylation of a CpG island ‘switches o’ the gene
that it is regulating. Many tumour suppressor genes are now recognised to be inactivated
by hypermethylation of the promoter region in malignant tumours. With inactivation of
a tumour suppressor gene, it must be considered there are two alleles, with the theory
that both alleles must be non-functioning and known as Knudson’s ‘two-hit’ hypothesis.
is is well explained by hereditary tumours, where an inherited mutation eliminates the
function of one allele, the so-called loss of heterozygosity (LOH), with a second somatic
mutation (‘hit’) required to facilitate the oncogenic potential of the mutations. It is now
known that tumour suppressors do not all t this model, and they can be haploinsucient
(gene only functions in the presence of two wild-type alleles), dominant negative (where
one mutated allele has an eect that dominates over the eect of the wild-type allele) or
gain of function.
Gene Sequencing
Recently a variety of next-generation sequencing (NGS) methods have been applied to the
eld. Methods involved include constructing a library of DNA fragments, which are amplied using polymerase chain reaction (PCR). e sequence of the DNA is determined by
synthesis, with dierent NGS platforms using dierent sequencing chemistry to determine
which complementary bases have been added to the original DNA strands. Using massive
parallel sequencing, this method is performed much more quickly and eciently than traditional Sanger sequencing.
Proteomics and Metabolomics
Proteomics is the proling of proteins in cells and serum by two-dimensional gel analysis
separating proteins by charge and mass, by X-ray crystallography and by mass spectrometry. Proteomics has the ability to identify post-translational modications, some of which
are cancer cell specic, which would not be detected by genetic or expression proling. e
power of this approach is particularly evident in cancer studies as it has the ability to compare the entire protein pattern of tumour tissue and normal tissue in a manner analogous to
comparative genomic hybridisation.
Metabolomics is the global analysis of metabolites but is a relatively new discipline and no
single technique is suitable for the analysis of all dierent types of molecule. erefore, a
mixture of techniques such as gas chromatography, high-pressure liquid chromatography
and capillary electrophoresis are used to separate metabolites and the molecules are then
identied using methods such as mass spectrometry. Metabolomics has already been applied
to the detection of oral cancer in saliva and serum.
Gene Therapy
Gene therapy oers a novel paradigm that leads to the destruction of tumour cells in cancer
patients. To date, the approaches to target specic cancer cells fall into four basic categories:
(1) chemosensitisation, (2) cytokine gene transfer, (3) inactivation of protooncogene production and (4) selective oncolytic viruses.
Selective sensitisation of cancer cells using gene therapy would be an ideal way to kill
cancer cells. Using this approach, the expected gene is delivered only to cancer cells and
then a second therapy (e.g. radiotherapy or chemotherapy) is used to induce killing in the
262 Head and Neck

MOLECULAR BIOLOGY AND GENE THERAPY
cells that express the transgene. Eciency and targeting have been shown to be dicult
in vivo largely due to the bystander eect, where an infected cell spreads the expressed
genes to the cells surrounding it via cell–cell contacts, reducing the method eciency in
the targeted cells.
e host immune response has been shown to play a role in cancer eradication. In addition to generalised suppression increasing the risk of carcinogenesis, it has been shown
that individuals with head and neck cancer lack an eective local immune response even
early in the disease. is dysfunction occurs as a result of the normal immune system not
recognising the tumour cells. Causes of this include immunological ignorance, downregulation of major histocompatibility complexes and loss of costimulatory receptor and
pathways. In some tumours, the cytokine stimulatory pathways (interleukin [IL]-2, interferon-gamma and IL-12) that normally upregulate the normal tumour immune response
are suppressed. One method to break this immune dysregulation is to overexpress the
downregulated cytokines.
Restoring the function of a key cellular gene whose dysfunction has resulted in cancer progression is a major goal of gene therapy. e most common mutations of key genes in squamous cell cancer of the head and neck are p53 and p16. p53 plays a role in triggering cell death
in many dierent pathways involving apoptosis. Gendicine®, a drug with modied adenovirus harbouring p53 gene, was approved in China in 2004, becoming the rst gene therapy
approved for clinical use in humans. However, the western version of Ad-p53 (Advexin®)
for the treatment of head and neck cancer was refused approval by the U. S. Food and Drug
Administration in 2008.
e future of restoring function via correction of genetic defects found in cancer may lie with
clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated
nuclease 9 (Cas9) gene editing. CRISPR-Cas9 utilises the DNA cutting action of the Cas9
protein to create double-stranded DNA breaks, has relative high eciency and accuracy for
disruption gene transcription and can be adapted for editing gene transcription. Safety trials
for the delivery of CRISPR-edited T cells into patients have started.
With increased knowledge of the genetic defects in cancer, delivery vectors aimed selectively
at tumour cells provide another research challenge. e translation of molecular biology
research into clinical practice, ‘from laboratory to bedside,’ is without a doubt the greatest
challenge facing the clinician scientist. Progress so far has been largely at the level of disease
classication, premorbid diagnosis and patient counselling. However, several discrete arms
to translational research have hinted at the future role of genetic analysis determining the
likely eectiveness of existing anti-cancer treatments.
KEY POINTS AND FUTURE RESEARCH
• Genetic sequencing data potentially provides more accurate diagnosis and prognosis
than conventional histopathological techniques.
• There is the potential for therapeutic restoration of DNA or protein function, as well as
exploitation of a genetic abnormality for targeting therapy.
• Although genomics and other omics has generated a large body of data, cancers
are complicated tissues. Future research may shift toward understanding the cancer
environment and how perhaps to target this in future therapeutic strategies.
• Our increased understanding of cellular oncogenesis will lead to the development of
novel cancer therapies in the years to come.
• Gene therapy is likely to be a part of these therapies.
A head and neck oncologist will need to understand both the viral vectors and their
strategies of implementation to offer a full range of treatment to the cancer patient.
Head and Neck 263

IMAGING OF THE NECK
53. IMAGING OF THE NECK
Introduction
Current imaging options for the head and neck include:
Plain X-rays: ey are limited to detecting ingested radiopaque foreign bodies, assess-
•
ing the dentition in oncological patients and those presenting with oor of mouth
abscesses.
Ultrasound (US): It is quick, non-invasive, readily available, inexpensive and does not
•
use ionising radiation. It is heavily operator dependent. Widely used for evaluating
neck lumps, lymph nodes, thyroid and salivary glands, and guiding ne-needle aspiration (FNA) or core biopsies.
Computed tomography (CT): is is used extensively in staging cancer patients and
•
detecting neck masses or abscesses. e entire neck can be scanned in a few seconds,
and images reconstructed in any plane. Intravenous iodinated contrast agent necessary due to its low so-tissue resolution. Radiation dose and dental artifact are an
important consideration.
Magnetic resonance imaging (MRI): is produces images with excellent so-tissue
•
contrast. It does not use ionising radiation. Contraindicated in certain patients with
metallic foreign bodies, prosthesis and implanted devices. Long acquisition times
result in motion artifact.
Positron emission tomography (PET): is is a functional imaging technique where
•
hyperme tabolic cel ls accumul ate tracer, usual ly uorine-18-labellfe d 2-uoro-2-deoxy-glucose (FDG). e combination of CT and PET allows accurate anatomical
localisation, which is especially useful in assessing patients with an unknown primar y,
and in post-treatment patients.
Contrast swallow: is is useful for assessing the presence of leaks following lar yngeal/
•
pharyngeal surgery. Videouoroscopy is important in assessing head and neck cancer
patients with dysphagia before or aer treatment.
Sialography: is provides excellent luminal depiction of glandular anatomy; how-
•
ever, it is invasive and can cause trauma or be unsuccessful.
Scintigraphy: is provides good quantication of gland function but poor anatomical
•
correlation and radiation burden.
Head and Neck Cancer
Cross-sectional imaging helps to assess the size, location and deep extension of tumour,
involvement of surrounding structures, presence of distant metastases and allows post-therapy surveillance and assessment of treatment.
Nasopharyngeal Cancer (NPC)
Locally aggressive, early metastases despite early primary.
•
CT allows assessment of the primary tumour and metastases (Figure 53.1).
•
MRI better at demonstrating so-tissue extent, intracranial extension and skull base
•
bone marrow changes (Figure 53.2).
PET-CT for staging, assessment of recurrence and evaluating the nasopharynx in
•
patients presenting with unknown primary.
Oral Cavity Tumours
Challenging radiologically due to surrounding anatomy.
•
Small tumours oen not visualised by imaging.
•
264 Head and Neck

IMAGING OF THE NECK
Figure 53.1 Axial CT showing nasopharyngeal carcinoma (white arrow) and retained secretions
left mastoid air cells (black arrow) due to Eustachian tube obstruction.
Figure 53.2 MRI showing left nasopharyngeal cancer extending into the pterygopalatine fossa
(black arrow) and vidian canal (white arrow) (a) and into the foramen rotundum (black arrow) (b).
CT shows better evaluation of cortical bone (Figure 53.3), but dental amalgam is a
•
frequent diagnostic issue.
MRI is better at characterising local tumour extent, perineural spread and bone mar-
•
row involvement.
Oropharyngeal Tumours
Oropharyngeal tumours include tonsil, base of tongue, so palate and posterior pha-
•
ryngeal wall cancers.
Oen present with a nodal mass and no obvious primary tumour.
•
CT/MRI both useful imaging modalities.
•
PET has a higher sensitivity for detection of primary tumour and cervical metastases.
•
PET-CT is slightly complicated by the normal physiological uptake in the oropharynx
•
(Figure 53.4).
Post-treatment PET-CT to assess therapy response.
•
Head and Neck 265

IMAGING OF THE NECK
Figure 53.3 Axial CT showing destruction of the inner cortex of the right mandible (arrow) in a
histologically proven intraosseous squamous cell carcinoma.
Figure 53.4 PET-CT showing increased activity in the right tongue base (white arrow) in a patient
presenting with a right-sided neck mass (black arrow) and no apparent primary on clinical examination or conventional CT. Note the normal physiological activity in the left tongue base.
Hypopharyngeal Tumours
Hypopharynx consists of the pyriform sinus/fossa, post-cricoid region and posterior
•
hypopharyngeal wall.
Imaging importantly evaluates the larynx, thyroid cartilage, and nodal status, and
•
usually results in tumour upstaging.
CT generally preferred modality (Figure 53.5).
•
PET-CT for detection of residual/recurrent tumour following treatment.
•
Laryngeal Tumours
Most common head and neck malignancy; the majority are squamous cell carcinoma
•
(SCC).
Imaging allows evaluation of submucosal disease, laryngeal cartilage and extra-
•
laryngeal structure involvement, state of the airway and nodal status.
266 Head and Neck

IMAGING OF THE NECK
Figure 53.5 Axial contrast CT showing a large hypopharyngeal posterior wall tumour extending
into the prevertebral muscles.
Figure 53.6 Axial contrast CT showing a large left transglottic tumour (long black arrow) with com-
pletely destroyed left arytenoid (white arrow) and sclerotic left cricoid cartilage (short black arrow).
CT is the preferred modality (Figure 53.6).
•
US can be used to identify extra-laryngeal spread (Figure 53.7).
•
PET-CT, CT or MRI is used for detection of residual/recurrent tumour following
•
treatment.
Neck Lumps
e imaging of patients presenting with a neck lump depends on the age of the patient,
clinical history and location of the mass.
Thyroglossal Duct Cyst
Intimately related to the hyoid bone, most below (65%) or at level of hyoid bone (15%).
•
75% occur in the midline, remainder up to 2 cm o the midline.
•
Imaging helps identify relationship to hyoid, presence or absence of normal thyroid
•
tissue, and any solid material within the cyst (Figure 53.8).
Head and Neck 267
Соседние файлы в папке Библиотека им академика М.И. Перельмана
